Your browser doesn't support javascript.
loading
The Association of Change in Weight During Radiotherapy Treatment With Clinical Outcomes in Patients With Stage I-III Esophageal Cancer.
Youssef, Andrew; Lavergne, Carrie; Niglas, Mark; N G Humphreys, Deanna; Fulton, Abrielle; Fathima, Ayesha; Youssef, Youssef.
Afiliación
  • Youssef A; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Lavergne C; R.S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health Oshawa, Oshawa, Ontario, Canada.
  • Niglas M; R.S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health Oshawa, Oshawa, Ontario, Canada.
  • N G Humphreys D; R.S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health Oshawa, Oshawa, Ontario, Canada.
  • Fulton A; R.S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health Oshawa, Oshawa, Ontario, Canada.
  • Fathima A; R.S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health Oshawa, Oshawa, Ontario, Canada.
  • Youssef Y; R.S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health Oshawa, Oshawa, Ontario, Canada.
Nutr Cancer ; 76(4): 356-363, 2024.
Article en En | MEDLINE | ID: mdl-38356287
ABSTRACT
Esophageal carcinoma (EC) and nutritional status are strongly linked due to swallowing disruptions and treatment-related toxicities. Therefore, malnutrition and weight loss (WL) occur in 85% and 79% of EC patients, respectively. WL is frequently associated with worse EC patient outcomes, however, WL during radiation therapy (RT) and EC patient outcomes have not been well established. The purpose of this study is to retrospectively review the association of WL during RT treatment of EC with clinical outcomes. Non-metastatic EC patients from our institution treated between 2010 and 2018, receiving total prescribed dose >40 Gy and aged >18 years, were included. Patients were analyzed by WL during RT, with categories of ≥5% vs. <5% and ≥10% vs. <10%. Patient characteristics and treatment regimens were similar across all WL groups. In univariate analysis, ≥5% and ≥10% WL were significantly associated with both worse overall survival (OS) and progression-free survival (PFS), and ≥10% WL was significantly associated with increased local recurrence. In multivariate analysis, ≥5% WL was significantly associated with OS and PFS. With both ≥5% and ≥10% WL throughout the radiation treatment being detrimental to OS and PFS. The importance of nutritional support in EC patients receiving radiotherapy is further validated.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma / Desnutrición Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Nutr Cancer Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma / Desnutrición Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Nutr Cancer Año: 2024 Tipo del documento: Article País de afiliación: Canadá